Synthesis of Aβ(1-42) and its derivatives with improved efficiency

Journal of Peptide Science

Volumn 13, Issue 2, 2007, Pages 94-99

  Zarándi, Márta ^a   Soós, Katalin ^a   Fülöp, Lívia ^a   Bozsó, Zsolt ^a   Datki, Zsolt ^a   Tóth, Gábor K ^a   Penke, Botond ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer's disease; Beta amyloid; Difficult sequences; Labeling of beta amyloid; Neurodegeneration; Synthesis

Indexed keywords

ACETIC ACID DERIVATIVE; AMYLOID BETA PROTEIN[1-42]; ANISOLE; CARBONYL DERIVATIVE; DICHLOROMETHANE; N,N DIMETHYLFORMAMIDE; PROTEIN DERIVATIVE; SOLVENT; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); FLUORESCENT DYE; NEUROTOXIN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN; METHODOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; QUANTUM YIELD; AMINO ACID SEQUENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; SYNTHESIS;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENT DYES; MOLECULAR SEQUENCE DATA; NEUROTOXINS; PEPTIDE FRAGMENTS;

EID: 33847103583     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.801     Document Type: Article

References (38)

1. Selkoe DJ. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 1993; 16: 403-409.
2. Mattson MP, Cheng B, Davis D, Bryant K, Liederburg I, Rydel RE. β amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 1992; 12: 376-389.
3. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates Aβ toxicity. Cell 1994; 77: 817-827.
4. Rush DK, Aschies S, Merriman MC. Intracerebral beta amyloid (25-35) produces tissue damage: is it neurotoxic? Neurobiol. Aging 1992; 13: 591-594.
5. Waite J, Cole GM, Frautsky SA, Connor DJ, Thai LJ. Solvent effects on beta protein toxicity in vivo. Neurobiol. Aging 1992; 13: 595-599.
6. Tickler AK, Clippingdale B, Wade JD. Amyloid-β as a "Difficult Sequence" in Solid Phase Peptide Synthesis. Protein Pept. Lett. 2004; 11: 377-384.
7. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/b amyloid peptide analogs. J. Biol. Chem. 1992; 267: 546-554.
8. Larsen BD, Holm A. Incomplete Fmoc deprotection in solid-phase synthesis of peptides. Int. J. Pept. Protein Res. 1994; 43: 1-9.
9. Johnson T. Quibell M, Owen D, Sheppard RC. A reversible protecting group for the amide bond in peptides: use in the synthesis of difficult sequences. J. Chem. Soc., Chem. Commun. 1993; 4: 369-372.
10. Quibell M, Turnell WG, Johnson T. Preparation and purification of β-Amyloid (1-43) via soluble, amide backbone protected intermediates. J. Org. Chem. 1994; 59: 1745-1750.
11. Clausen N, Goldammer C, Jauch K, Bayer E. Backbone protection: synthesis of difficult sequences using N-a-Tmob protected amino acid derivatives. In Peptides 1995. Chemistry, Structure and Biology, Kaumaya PTP, Hodges RS (eds). Mayflower Scientific: UK, 1996; 71-72.
12. Haack T, Mutter M. Serine-derived oxazolidines as secondary structure disrupting, solubilizing building blocks in peptidesynthesis. Tetrahedron Lett. 1992; 33: 1589-1592.
13. Mutter M, Nefzi A, Sato T, Sun X, Wahl F, Wahl T. Pseudo-prolines (ΨPro) for accessing 'inaccessible peptides'. Pept. Res. 1995; 8: 145-153.
14. White P, Keyte JW, Bailey K, Bloomberg G. Expediting the fmoc solid phase synthesis of long peptides through the application of dimethyloxazolidine dipeptides. J. Pept. Sci. 2004; 10: 18-26,
15. Sampson WR, Patsiouras H, Ede NJ. The synthesis of 'Difficult' peptides using 2-Hydroxy-4-Methoxybenzyl or pseudoproline Amino Acid Building Blocks: a Comparative Study. J. Pept, Sci. 1999; 5: 403-409.
16. Carpino LA. 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive. J. Am. Chem. Soc. 1993; 115: 4397-4398.
17. Fukuda H, Shimizu T, Nakajima M, Mori H, Shirasawa T. Synthesis, aggregation, and neurotoxicity of the Alzheirner's Aβ1-42 amyloid peptide and its isoaspartyl isomers. Bioorg. Med. Chem. Lett. 1999; 9: 953-956.
18. El-Agnaf OMA, Goodwin H, Sheridan JM, Frears ER, Austen BM. Improved solid-phase syntheses of amyloid proteins associated with neurodegenerative diseases. Protein Pept. Lett. 2000; 7: 1-8.
19. Hyde C, Johnston T, Sheppard RC. Internal aggregation during solid phase peptide synthesis: dimethyl sulfoxide as a powerful dissociating solvent. J. Chem. Soc., Chem. Commun. 1992; 21: 1573-1575.
20. Hyde C, Johnson T, Owen D, Quiben M, Sheppard RC. Some 'difficult sequences' made easy. Int. J. Pept. Protein Res. 1994; 43: 431-440.
21. Miranda L, Alewood PF. Accelerated chemical synthesis of peptides and small proteins. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 1181-1186.
22. Tam JP, Lu Y-A. Coupling difficulty associated with interchain clustering and phase transition in solid phase peptide synthesis. J. Am. Chem. Soc. 1995; 117: 12058-12063.
23. Fields GB, Fields CG. Solvation effects in solid-phase peptide synthesis. J. Am. Chem. Soc. 1991; 113: 4202-4207.
24. Milton SCF, Milton RC, De L. An improved solid-phase synthesis of a difficult-sequence peptide using hexaflouro-2-propanol. Int. J. Pept. Protein Res. 1990; 36: 193-196.
25. Zhang L, Goldammer C, Henkel B, Zuhl F, Panhaus G, Jung G, Bayer E. 'Magic mixture', a powerful solvent system for solid-phase synthesis of 'difficult sequences'. In Innovations and Perspectives in Solid Phase Synthesis, 1994; 3rd International Symposium, Epton R (ed.). Mayflower Scientific Ltd: Birmingham, 1994; 711-716.
26. Narita M, Honda S, Umeyama H, Obana S. The solubility of peptide intermediates in organic solvents. Bull. Chem. Soc. Jpn. 1988; 61: 281-284.
27. Stewart JW, Klis WA. Polystyrene-based solid phase peptide synthesis: the state of the art. In Innovations and Perspectives in Solid Phase Synthesis, Epton R (ed.). SPCC (UK) Ltd: Birmingham, 1990; 1-9.
28. α- deprotecting reagent for the fluorenylmethoxycarbonyl group in continuous flow solid phase peptide synthesis. Pept. Res. 1991; 4: 194-199.
29. Kates SA, Sole NA, Beyermann M, Barany G, Albericio F. Optimized preparation of deca(L-alanyl)-L-valinamide by 9-fluorenylmethyloxycarbonyl (Fmoc) solid-phase synthesis on polyethylene glycol-polystyrene (PEG-PS) graft supports, with 1,8-diazobicyclo [5.4.0]-undee-7-ene (DBU) deprotection. Pept. Res. 1996; 9:106-113.
30. Dettin M, Pegoraro S, Rovero P, Biccato S, Bagno A, di Bello C. Spps of difficult sequences. A comparison of chemical conditions, synthetic strategies and on-line monitoring. J. Pept. Res. 1997; 49: 103-111.
31. α-Fmoc Deprotection Reagent. J. Pept. Res. 2001; 7: 488-494.
32. Fülöp L, Penke B, Zarandi M. Synthesis and fluorescent labeling of beta-amyloid peptides. J. Pept. Res. 2001; 7: 397-401.
33. Datki Z, Juhasz A, Galfi M, Soos K, Papp R, Zadori D, Penke B. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res. Bull. 2003; 62: 223-229.
34. Pike CJ, Overman MJ, Cotman CW. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro, d. Biol. Chem. 1995; 270: 23895-23898.
35. Takeda K, Araki W, Akiyama H, Tabira T. Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain. FASEB J. 2004; 18: 1755-1757.
36. Huang H, Rabenstein DL. A cleavage cocktail for methionine-containing peptides, J, Pept. Res. 1999; 53: 548-553,
37. Tam JP, Heath WF, Merrifield RB. Mechanisms for the removal of benzyl protecting groups in synthetic peptides by txifluoromethanesulfonie acid-trifluoroacetic acid-dimethyl sulfide. J. Am. Chem. Soc. 1986; 108: 5241-5242.
38. Khalfan H, Abuknesha R, Randweaver M, Price RG, Robinson D. Aminomethyl coumarin acetic-acid- a new fluorescent labeling agent for proteins. Histochem. J. 1986; 18: 497-499.